newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals Reports First-Quarter Financial Results

ENGLEWOOD, Colo., May 16, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis in the knee and potentia